Open AccessAnalysis on Effect of Jinshuibao Capsule Combined Treatment on Newly Diagnosed Pulmonary Tuberculosis
Author(s) -
Xinmin Yu
Publication year - 2015
Publication title -
advanced emergency medicine
Language(s) - English
Resource type - Journals
ISSN - 2315-456X
DOI - 10.18686/aem.v4i3.12
Subject(s) - medicine , capsule , sputum , pulmonary tuberculosis , tuberculosis , gastroenterology , surgery , clinical pathology , clinical treatment , lesion , treatment and control groups , pathology , traditional medicine , botany , biology
Objective: To discuss the clinical effect of jinshuibao capsule combined treatment on newly diagnosed pulmonary tuberculosis. Method : 62 cases of newly diagnosed pulmonary tuberculosis patients, who were treated in our hospital from January 2011 to January 2012, were served as the object of study. They were randomly divided into control group and treatment group. Patients in the control group received a single 2SHRZ/4HR chemotherapy, while the treatment group received jinshuibao capsule combined treatment on the base of control group. The improvement of clinical symptoms, chest X-ray film and laboratory examination results of both groups were compared and analysed. Results : The total effective rate of clinical treatment, lesion absorption, sputum negative conversion and improvement rate of clinical symptom of treatment group was obviously better than the control group. The difference of clinical effect between two groups was statistically significant (p < 0.05). Conclusion : Jinshuibao capsule combined treatment has satisfactory clinical effect on newly diagnosed pulmonary tuberculosis.